Invite only: Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&D supports researchers developing and testing countermeasures to improve UK preparedness for CBRN incidents.
Expression of interest: Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&D supports researchers developing and testing medical countermeasures to improve UK domestic preparedness.
NIH funds research on radiation and chemical injuries, injury models, diagnostics, and medical countermeasures for radiological, nuclear, or chemical emergencies; clinical trials are not allowed.
UKRI Translation: MRC Proof of Concept: stage one supports academic teams developing and testing medical interventions and research tools to address significant health needs and advance patient benefit.
Experimental medicine: invited stage two application supports academic teams testing disease mechanisms through human interventions to generate insights that could inform future therapies or diagnostics.
Doctoral focal award: chemical threat reduction supports doctoral students through research and cohort-based training to build chemical incident expertise and protect UK health and national security.